Global Intracranial Aneurysm Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others.By End Use;
Hospitals, Clinics, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Intracranial Aneurysm Market (USD Million), 2021 - 2031
In the year 2023, the Global Intracranial Aneurysm Market was valued at USD 1,029.69 million. The size of this market is expected to increase to USD 2,276.31 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 12.0%.
The market is driven by a combination of factors, including increasing incidence rates of intracranial aneurysms, rising awareness about preventive healthcare measures, and advancements in diagnostic imaging technologies. With the aging population and lifestyle factors such as hypertension and smoking contributing to the prevalence of intracranial aneurysms, there is a growing demand for innovative diagnostic tools and treatment modalities that can accurately identify and manage these conditions.
Key players in the market are investing heavily in research and development to introduce novel therapies and devices aimed at improving patient outcomes and reducing the risks associated with intracranial aneurysms. From minimally invasive endovascular procedures to advanced surgical techniques, healthcare providers have access to a wide array of treatment options tailored to individual patient needs. Technological advancements such as advanced imaging techniques, computer-aided diagnosis, and the integration of artificial intelligence are reshaping the landscape of intracranial aneurysm diagnosis and treatment planning. These innovations enable healthcare professionals to make more accurate and timely clinical decisions, ultimately improving patient care and prognosis.
The market also presents significant opportunities for collaboration between healthcare providers, medical device manufacturers, and pharmaceutical companies to develop comprehensive treatment algorithms and guidelines that optimize patient outcomes. Furthermore, there is a growing focus on patient-centered care, with initiatives aimed at enhancing patient education, support, and access to resources for better disease management and long-term care.
Global Intracranial Aneurysm Market Recent Developments
- In May 2023,Stryker Corporation acquiredCerus Endovascular Ltd., a medical devices company involved in making neurointerventional devices for the treatment of intracranial aneurysms. With this acquisition, Stryker aims to expand its product portfolio foraneurysm treatment solutions
- In October 2023, a study published in the BMJ Journal of Neurointerventional Surgery demonstrated that PreSize, an AI software, is more accurate thanhuman clinicians in predicting placement of a stent in a patient’s brain. This development shows how the integration of AI could provide growth opportunities for the players operating in the market
- In June 2022, the Indian subsidiary ofMedtronic plc launched pipeline vantage embolization device in India for the treatment of brain aneurysms
Segment Analysis
By type, the market distinguishes between different classifications of intracranial aneurysms, such as saccular, fusiform, and dissecting aneurysms. Each type presents unique characteristics and clinical considerations, influencing treatment decisions and patient outcomes. This segmentation enables healthcare professionals to customize interventions and optimize care based on the specific characteristics of the aneurysm.
The segmentation by end use categorizes stakeholders involved in the diagnosis, treatment, and management of intracranial aneurysms. This includes hospitals, ambulatory surgical centers, diagnostic imaging centers, and research institutions. Understanding the preferences and requirements of each end user group is essential for the development and adoption of effective therapies and technologies.
Geographically, the market analysis covers key regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Variations in healthcare infrastructure, regulatory frameworks, and disease prevalence rates across these regions influence market dynamics and demand for intracranial aneurysm treatments. This segmentation facilitates targeted market strategies and resource allocation to capitalize on growth opportunities and address specific challenges in each region.
Global Intracranial Aneurysm Segment Analysis
In this report, the Global Intracranial Aneurysm Market has been segmented by Type, End Use, and Geography.
Global Intracranial Aneurysm Market, Segmentation by Type
The Global Intracranial Aneurysm Market has been segmented by Type into Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others.
Surgical clipping, a traditional technique, involves the placement of a metal clip at the neck of the aneurysm to prevent blood flow into the bulging vessel, thereby reducing the risk of rupture. Endovascular coiling, another widely utilized approach, involves the insertion of platinum coils into the aneurysm via catheterization, promoting blood clotting and ultimately sealing off the aneurysm. The market includes flow diverters, a relatively newer innovation in intracranial aneurysm treatment. Flow diverters are stent-like devices deployed across the neck of the aneurysm to divert blood flow away from the weakened vessel wall, promoting natural healing and thrombosis within the aneurysm sac. This technique offers a minimally invasive alternative to traditional surgical interventions, particularly for complex or large aneurysms.
The segmentation encompasses other emerging and adjunctive therapies, such as balloon-assisted coiling, stent-assisted coiling, and intrasaccular flow disruption devices. These techniques may be employed either as standalone treatments or in combination with surgical clipping or endovascular coiling to achieve optimal outcomes based on the specific characteristics of the aneurysm and patient factors.Each treatment modality within the segmentation offers unique advantages and considerations, catering to the diverse needs and preferences of patients and healthcare providers. Factors such as aneurysm size, location, morphology, and patient's overall health play a crucial role in determining the most appropriate treatment approach.
Global Intracranial Aneurysm Market, Segmentation by End Use
The Global Intracranial Aneurysm Market has been segmented by End Use into Hospitals, Clinics, and Others.
Hospitals, as primary providers of specialized medical care, constitute a significant segment within the market. Equipped with advanced diagnostic imaging facilities, surgical theaters, and multidisciplinary teams of neurosurgeons, interventional radiologists, and neurologists, hospitals play a pivotal role in the comprehensive management of intracranial aneurysms. They offer a range of treatment options, including surgical clipping, endovascular coiling, and flow diversion procedures, catering to the diverse needs of patients with intracranial aneurysms.
Clinics represent another essential segment within the market, providing outpatient services for diagnosis, follow-up care, and minimally invasive interventions. Neurology clinics, interventional radiology centers, and specialized neurosurgery clinics offer consultations, imaging studies, and outpatient procedures such as diagnostic angiography and endovascular coiling. Clinics often serve as accessible points of entry for patients seeking initial evaluation and ongoing management of intracranial aneurysms, facilitating timely intervention and coordinated care pathways.
The "Others" category encompasses various healthcare settings, including ambulatory surgical centers, diagnostic imaging facilities, and research institutions, contributing to the broader ecosystem of intracranial aneurysm care. Ambulatory surgical centers may offer specialized procedures such as endovascular coiling on an outpatient basis, providing convenience and cost-effective care options for patients. Diagnostic imaging facilities play a crucial role in the accurate diagnosis and surveillance of intracranial aneurysms, utilizing advanced imaging modalities such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA).
Global Intracranial Aneurysm Market, Segmentation by Geography
In this report, the Global Intracranial Aneurysm Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Intracranial Aneurysm Market Share (%), by Geographical Region, 2024
North America emerges as a significant region within the market, driven by advanced healthcare systems, extensive research and development activities, and high awareness levels among healthcare professionals and patients. The region benefits from a robust network of hospitals, specialized clinics, and academic medical centers equipped with state-of-the-art diagnostic and treatment facilities for intracranial aneurysms.
Europe, similarly, boasts well-established healthcare systems and a strong emphasis on patient care and safety. The region witnesses significant investments in medical technology and research, fostering innovation in intracranial aneurysm diagnosis and treatment. Asia Pacific, characterized by its large and diverse population, presents immense growth potential for the market. Rapid urbanization, increasing healthcare expenditures, and improving access to healthcare services drive the demand for advanced treatment modalities for intracranial aneurysms in this region.
The Middle East and Africa region is witnessing a gradual rise in healthcare investments and infrastructure development, albeit with varying levels of healthcare access and quality across different countries. Latin America, similarly, presents opportunities for market growth, fueled by improving healthcare access, rising disposable incomes, and increasing awareness about neurological conditions such as intracranial aneurysms. However, challenges such as disparities in healthcare access and resource constraints may impact market dynamics in these regions.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Intracranial Aneurysm Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers:
- Aging Population
- Technological Advancements
-
Rising Incidence Rates - One of the primary factors contributing to the increasing incidence of intracranial aneurysms is demographic shifts, particularly the aging population. As populations worldwide continue to age, there is a corresponding rise in the prevalence of age-related risk factors such as hypertension, atherosclerosis, and other vascular diseases, which are closely associated with the development of intracranial aneurysms.
Lifestyle factors such as smoking, excessive alcohol consumption, and stress contribute to the burden of intracranial aneurysms, exacerbating the risk of vascular damage and aneurysm formation. Changes in dietary habits and physical inactivity also play a role in the epidemiology of intracranial aneurysms, highlighting the importance of preventive health measures and lifestyle modifications in reducing disease incidence. Additionally, advances in medical imaging technologies and diagnostic techniques have improved the detection and diagnosis of intracranial aneurysms, leading to higher rates of incidental detection during routine medical examinations and imaging studies.
The rising incidence of intracranial aneurysms underscores the urgent need for effective preventive strategies, early detection, and innovative treatment modalities to mitigate the risks associated with this condition. Healthcare providers, policymakers, and industry stakeholders must collaborate to raise awareness about intracranial aneurysms, promote healthy lifestyle behaviors, and invest in research and development to advance diagnostic and therapeutic interventions. By addressing the underlying drivers of rising incidence rates, the Global Intracranial Aneurysm Market can better meet the evolving needs of patients and healthcare systems worldwide, ultimately improving outcomes and reducing the burden of this potentially life-threatening condition.
Restraints:
- Treatment Complexity
- High Healthcare Costs
-
Limited Access - In many parts of the world, access to neurosurgical care is constrained by factors such as geographical barriers, socioeconomic disparities, and insufficient healthcare resources. Rural and remote areas often lack neurosurgical centers equipped to perform complex procedures such as surgical clipping or endovascular coiling. As a result, patients living in these regions may face delays in accessing specialized care or may have to travel long distances to urban centers, leading to logistical challenges and increased financial burden.
Disparities in healthcare infrastructure and resources between high-income and low-income regions contribute to disparities in access to intracranial aneurysm treatment. Low- and middle-income countries may struggle to invest in advanced medical technologies and personnel training, limiting the availability of specialized services for intracranial aneurysm diagnosis and treatment. Additionally, socioeconomic factors such as lack of health insurance coverage and out-of-pocket expenses can further hinder access to care for underserved populations.
Limited access to specialized healthcare services not only delays diagnosis and treatment but also compromises patient outcomes and exacerbates healthcare disparities. Individuals with undiagnosed or untreated intracranial aneurysms are at increased risk of experiencing a rupture, which can result in devastating consequences such as hemorrhagic stroke and permanent neurological deficits. Addressing the restraint of limited access requires a multifaceted approach, including investment in healthcare infrastructure, expansion of telemedicine services, implementation of community outreach programs, and efforts to improve healthcare financing and insurance coverage.
Opportunities:
- Innovative Therapies
- Advancements in Imaging
-
Collaborative Research - One key aspect of collaborative research is the exploration of the underlying mechanisms and risk factors associated with intracranial aneurysm formation and rupture. By leveraging diverse perspectives and methodologies, researchers can unravel the genetic, environmental, and hemodynamic factors contributing to aneurysm development, enabling more accurate risk stratification and personalized treatment approaches.
Collaborative research facilitates the development and validation of novel diagnostic tools and imaging techniques for early detection and characterization of intracranial aneurysms. Advanced imaging modalities, such as high-resolution magnetic resonance imaging (MRI) and computational fluid dynamics (CFD) modeling, hold promise for improving the accuracy and predictive value of aneurysm assessment, guiding treatment decisions, and monitoring disease progression over time.
Collaborative efforts drive innovation in treatment modalities and devices, such as the development of next-generation endovascular devices, bioresorbable implants, and targeted drug delivery systems. By combining expertise in materials science, bioengineering, and clinical neurology, researchers can design and optimize interventions that enhance efficacy, durability, and patient outcomes while minimizing risks and complications associated with traditional approaches.
Competitive Landscape Analysis
Key players in Global Intracranial Aneurysm Market include:
- Stryker Corporation
- MicroPort Scientific Corporation.
- Johnson & Johnson Services, Inc.
- MicroVention Inc.
- B. Braun Melsungen AG
- Integra LifeSciences
- RAUMEDIC AG
- Terumo Corporation
- Delta Surgical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Intracranial Aneurysm Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Aging Population
-
Technological Advancements
-
Rising Incidence Rates
-
- Restraints
-
Treatment Complexity
-
High Healthcare Costs
-
Limited Access
-
- Opportunities
-
Innovative Therapies
-
Advancements in Imaging
-
Collaborative Research
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Intracranial Aneurysm Market, By Type, 2021 - 2031 (USD Million)
-
Surgical Clipping
-
Endovascular Coiling
-
Flow Diverters
-
Others
-
- Global Intracranial Aneurysm Market, By End Use, 2021 - 2031 (USD Million)
-
Hospitals
-
Clinics
-
Others
-
- Global Intracranial Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Intracranial Aneurysm Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Stryker Corporation
- MicroPort Scientific Corporation.
- Johnson & Johnson Services, Inc.
- MicroVention Inc.
- B. Braun Melsungen AG
- Integra LifeSciences
- RAUMEDIC AG
- Terumo Corporation
- Delta Surgical
- Company Profiles
- Analyst Views
- Future Outlook of the Market